Ralph A Heasley

Title: Ralph A. Heasley: Innovator in Tranexamic Acid Formulations

Introduction

Ralph A. Heasley is a notable inventor based in Webster Grove, MO (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of tranexamic acid formulations. With a total of 9 patents to his name, Heasley has focused on enhancing patient compliance and minimizing adverse effects associated with medication.

Latest Patents

Heasley's latest patents include innovative formulations of tranexamic acid. One of his key inventions is a modified release oral tranexamic acid formulation, which aims to improve treatment methods. Another significant patent addresses tranexamic acid formulations designed to reduce adverse effects. This formulation includes at least one agent that decreases the release of tranexamic acid in the stomach, thereby minimizing nausea, vomiting, and other gastric issues that may arise during therapy. Heasley has developed both extended release and delayed release formulations, which enhance patient compliance by reducing the adverse effects of tranexamic acid therapy.

Career Highlights

Ralph A. Heasley is currently associated with Ferring B.V., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of tranexamic acid in clinical settings.

Collaborations

Heasley has collaborated with notable colleagues, including Keith A. Moore and Jeffrey S. Greiwe. These partnerships have contributed to the successful development of his patented formulations.

Conclusion

Ralph A. Heasley stands out as a significant figure in the field of pharmaceutical innovations, particularly in the area of tranexamic acid formulations. His work not only advances medical treatments but also enhances patient experiences through reduced side effects.